Search

everythinglearnresearchcommunity

for

Search:↓

Female donor to male recipient sex mismatch and positive ACA-IgG are key risk factors for vitiligo and alopecia areata in chronic GvHD patients.

Finasteride doesn't effectively treat hair loss in postmenopausal women.

In STSD patients, the body compensates for low androgen levels by increasing another enzyme's activity.

Measuring plasma testosterone glucosiduronate is a reliable way to detect high male hormone levels in women.

Removing both ovaries treated the woman's excess male hormone symptoms.

People with androgenetic alopecia have different lipid levels in their blood, which vary between men and women, and may be linked to a higher risk of metabolic syndrome.

Ovarian hyperthecosis caused high testosterone and virilization symptoms in a 60-year-old woman, which improved after surgery.

The true incidence of post-Finasteride syndrome is unclear, and more research is needed.

Sunscreen use is linked to frontal fibrosing alopecia, especially in males.

Female pattern hair loss diagnosis is challenging and should use dermoscopy and histopathology instead of pattern recognition, as hormones may not always be the cause.

Older Black women in the UK feel more confident and engaged when their hair is visible and celebrated.

Androgenetic alopecia starts earlier in males than females, with different treatments, and is linked to income, education, alcohol use, and mental health.

A 5-year-old girl with McCune-Albright syndrome grew abnormal hair due to the drug tamoxifen.

Many treatments for hair loss lack proper testing and FDA approval, so their effectiveness is uncertain.

Finasteride, a hair loss drug, can cause long-lasting sexual side effects like low libido and erectile dysfunction.

Dermatologists' treatment of alopecia areata is inconsistent, especially for children and advanced stages.

Hormone therapy with estradiol and spironolactone can regrow scalp hair in transgender women by lowering testosterone to female levels.

The update highlights that non-classic congenital adrenal hyperplasia is common in women with excess male hormones, requires specific hormone tests for diagnosis, and has various treatment options depending on age and symptoms.

Prostaglandins don't genetically contribute to hair loss.

Women with congenital adrenal hyperplasia (CAH) have more sexual function issues than those with polycystic ovary syndrome (PCOS), but physical activity can improve sexual functioning in all women.

Men using hair loss drugs like finasteride may experience sexual side effects like erectile dysfunction, but it's unclear who will be affected and when. Treating depression and sexual symptoms is suggested, as these men often have higher rates of both. More research is needed to understand why these side effects occur.

Hispanic and Black patients are underrepresented in alopecia areata clinical trials.

Androgen-producing ovarian tumors can cause male-pattern hair loss in women.

The document concludes that hormonal biomarkers are key for diagnosing hyperandrogenemia in women and hypogonadism in men.

A new genetic variant causes trichothiodystrophy in two brothers, but their mother may carry it without showing symptoms.

5α-reductase inhibitors can cause serious and possibly lasting sexual and psychological side effects.

Hirsutism in young girls can have various causes beyond PCOS, so diagnoses should be reconsidered if treatments don't work.